BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22241353)

  • 1. [Initial report of strontium-89 chloride treatment for painful osseous metastases at Sakai Municipal Hospital].
    Ikeda H; Ichida W; Nakaseko Y; Kato R; Fujimoto M; Nakanishi K; Sugimoto M; Maeda M; Hashimoto T; Harada K
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):63-8. PubMed ID: 22241353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
    Ouyang W; Liu JH; Liu WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Internal strontium-89 radiotherapy for malignant bony metastasis].
    Lou C; Zhang D; Yu L
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined treatment for pain from bone metastases in patients with prostate cancer].
    Ren X; Ying J; Yao D; Ye C; Jiang Y
    Zhonghua Nan Ke Xue; 2004 Mar; 10(3):188-90. PubMed ID: 15080063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Painful osseous metastases.
    Smith HS
    Pain Physician; 2011; 14(4):E373-403. PubMed ID: 21785487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of thyroid medullary carcinoma with multiple painful bone metastases successfully treated with strontium-89 chloride].
    Oshiro C; Kamigaki S; Arai T; Nakamura Y; Fukunaga M; Ichida W; Ikeda H
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):951-3. PubMed ID: 22705690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strontium-89: a desirable therapeutic for bone metastases of prostate cancer].
    Ma YB; Yan WL; Dai JC; Xu F; Yuan Q; Shi HH
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):819-22. PubMed ID: 18998467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.
    Turner SL; Gruenewald S; Spry N; Gebski V;
    Br J Cancer; 2001 Feb; 84(3):297-302. PubMed ID: 11161391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium-89 in palliative treatement of painfull bone metastases.
    Zorga P; Birkenfeld B
    Ortop Traumatol Rehabil; 2003 Jun; 5(3):369-73. PubMed ID: 18034034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study.
    Nilsson S; Strang P; Ginman C; Zimmermann R; Edgren M; Nordström B; Ryberg M; Kälkner KM; Westlin JE
    J Pain Symptom Manage; 2005 Apr; 29(4):352-7. PubMed ID: 15857738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases.
    Zenda S; Nakagami Y; Toshima M; Arahira S; Kawashima M; Matsumoto Y; Kinoshita H; Satake M; Akimoto T
    Int J Clin Oncol; 2014 Aug; 19(4):739-43. PubMed ID: 23877652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strontium-89 diagnosis and therapy of bone metastases].
    Ryzhkov AD; Gabuniia RI; Kochergina NV; Shiriaev SV; Zimina OG
    Vopr Onkol; 2004; 50(6):658-62. PubMed ID: 15755058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
    Tu SM; Kim J; Pagliaro LC; Vakar-Lopez F; Wong FC; Wen S; General R; Podoloff DA; Lin SH; Logothetis CJ
    J Clin Oncol; 2005 Nov; 23(31):7904-10. PubMed ID: 16258090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ
    J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [89SrCl2 in the treatment of cancer patients with bone metastasis and pain].
    Sun D; Chu Y; Lou C; Wang QJ; Zhan HW; He GQ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):499-501. PubMed ID: 16188153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients].
    Nishio M; Sano M; Tamaki Y; Fujii H; Shima Y; Fujimoto H; Kubo A; Koizumi K; Tokuda Y; Adachi S; Sumiyoshi Y; Hasegawa T; Eguchi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):399-410. PubMed ID: 16334394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N; Batraki M; Divgi CR
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of repeated systematic radiotherapy for generalized prostate cancer].
    Kiselev EN; Korytova LI; Karelin MI
    Vopr Onkol; 2005; 51(6):689-91. PubMed ID: 17037036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.